# Ain Shams University: Phase 3 study in Surgical Site Infection (SSI), Spine Diseases (416 participants)

**Score:** 45/100

| Field | Value |
|---|---|
| Sponsor | Ain Shams University |
| Sponsor type | Academic and hospital |
| Study | Efficacy of Intrawound Vancomycin in Spine Surgery |
| NCT ID | NCT07866157 |
| Phase | Phase 3 |
| Status | completed |
| Conditions | Surgical Site Infection (SSI); Spine Diseases |
| Intervention types | drug, procedure |
| Target enrollment | 416 |
| Site countries | Egypt |
| Posted | 2026-10-08 |
| Planned start | 2023-12-02 |
| Event | Newly registered study |
| Event date | 2026-10-08 |

## Why this score
- Phase 3: multi-site, larger budget.
- 416 participants planned.

Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 (https://clinicaltrials.gov/study/NCT07866157). Last refreshed: 2026-11-04T06:04:38.232Z.
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.